To Vaccinate Or Not To Vaccinate?

That is the Swine Flu question

By Greg Szymanski, JD
May 6, 2009

According to the U.S. Food and Drug Administration (FDA), it approved today a new manufacturing facility to be used to produce influenza virus vaccines.

The facility, located in Pennsylvania, is for seasonal influenza vaccine production and could be used for the production of vaccine against the new 2009 H1N1 influenza strain.

“Increased manufacturing capacity for influenza vaccine is critical to our preparedness for an influenza pandemic,” said Jesse Goodman, M.D., M.P.H., the FDA’s acting chief scientist and deputy commissioner for scientific and medical programs.

“This action also enhances the ability to produce and provide vaccines to protect the public from seasonal influenza, still estimated to cause more than 30,000 deaths per year. Thanks to strategic investments by the federal government and proactive efforts and engagement by the FDA and the vaccine industry, our nation’s preparedness has come a long way over the last five years.”To read the rest of this article subscribe now!